Browsing by Author "Rios Acevedo, Jhon Jairo (Director)"
Now showing 1 - 1 of 1
Results Per Page
Sort Options
Item Caracterización de incidencias de reacciones adversas medicamentosas asociadas a anticoagulantes y diseño de guía de uso clínico para pacientes anticoagulados(Universidad Santiago de Cali, 2024) Vélez Hernández, Natalia; Rios Acevedo, Jhon Jairo (Director)Pathologies associated with poor blood coagulation such as DVT (deep vein thrombosis), stroke (cerebrovascular accident), venous thromboembolism, pulmonary embolism, among others; These require a drug that helps the clot that is produced inside a vein or artery not to occlude it, at this point is when anticoagulants play a very important role, being one of the most widely used groups of drugs in Colombia, for this reason a retrospective study was conducted by reviewing 150 clinical histories of anticoagulated patients in the health provider institution Hospital Universitario del Valle, in the period from 2018 to 2022, in order to identify what is the incidence of a patient to present or not an ADR (adverse drug reaction) or AE (adverse event). The age group between 40-90 years was identified, where the prevalence of presenting an undesired reaction during treatment varied according to the anticoagulant used: for Enoxaparin it was 74%, for Dalteparin it was 71%, for Apixaban it was 40% and for Heparin it was 89%. On the other hand, it was possible to identify that the most frequent adverse event was nausea with approximately 40%. Following this, the Chi-square test was performed, where correlation was observed between different variables such as the adverse event presented, the concentration of the anticoagulant and the duration of treatment; by means of these data, it was observed which of the hypotheses was fulfilled for each type of analysis, finding that there is no relationship of influence in terms of age vs. anticoagulant administered and age vs. frequency of presenting an undesired event, while there was a relationship between the other cases already mentioned.